W911QY21C0031 — MERCK SHARP & DOHME LLC — Department of Defense ($2,205,000,834)

COVID-19 ORAL ANTIVIRAL MK-4482 (MOLNUPIRAVIR) Recipient: MERCK SHARP & DOHME LLC Obligated amount: $2,205,000,834 Awarding agency: Department of Defense (Department of the Army) Procurement instrument identifier (PIID): W911QY21C0031 Start date: 2021-06-07 End date: 2023-07-13

Related documents

• N0001917C0045 — LOCKHEED MARTIN CORPORATION — Department of Defense ($1,443,726,579)#604829
• N0003015C0100 — LOCKHEED MARTIN CORP — Department of Defense ($1,533,695,409)#604784
• H9240019F0152 — GLOBAL ENTERPRISE SOLUTIONS, INC. — Department of Defense ($80,285,578)#601451
• N0002413C5225 — LOCKHEED MARTIN CORPORATION — Department of Defense ($824,000,835)#605408
• H9241522F0005 — GLOBAL ENTERPRISE SOLUTIONS, INC. — Department of Defense ($83,003,457)#601439